Can apoA-I infusion decrease cardiovascular events?

Graphical AbstractCan LDL-C-lowering and apoA-I mimetic infusion be complementary approaches to reduce the risk of recurrent events in post-myocardial infarction patients with high baseline LDL-C levels? LCAT, lecithin cholesterol acyl transferase; LDL-C, LDL cholesterol.Open in new tabDownload slide